Cargando…
Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy
A major goal of cancer nanotherapy is to use nanoparticles as carriers for targeted delivery of anti-tumour agents. The drug–carrier association after intravenous administration is essential for efficient drug delivery to the tumour. However, a large number of currently available nanocarriers are se...
Autores principales: | Zhao, Yiming, Fay, François, Hak, Sjoerd, Manuel Perez-Aguilar, Jose, Sanchez-Gaytan, Brenda L., Goode, Brandon, Duivenvoorden, Raphaël, de Lange Davies, Catharina, Bjørkøy, Astrid, Weinstein, Harel, Fayad, Zahi A., Pérez-Medina, Carlos, Mulder, Willem J. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833858/ https://www.ncbi.nlm.nih.gov/pubmed/27071376 http://dx.doi.org/10.1038/ncomms11221 |
Ejemplares similares
-
Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy
por: Pérez-Medina, Carlos, et al.
Publicado: (2016) -
Conformational Changes in High-Density Lipoprotein
Nanoparticles Induced by High Payloads of Paramagnetic Lipids
por: Ramos-Cabrer, Pedro, et al.
Publicado: (2016) -
Utility of Atherosclerosis Imaging in the Evaluation of High-Density Lipoprotein–Raising Therapies
por: Duivenvoorden, Raphaël, et al.
Publicado: (2011) -
Tumor Microenvironment Targeted Nanotherapy
por: Fernandes, Clara, et al.
Publicado: (2018) -
Imaging-assisted anticancer nanotherapy
por: Dasgupta, Anshuman, et al.
Publicado: (2020)